Office of Research Academic and Innovation, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 10400, Bangkok, Thailand.
Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University, 40002, Khon Kaen, Thailand.
J Ovarian Res. 2021 May 12;14(1):66. doi: 10.1186/s13048-021-00819-8.
Dysregulation of immune response is associated with development of endometriosis. The study aim was to evaluate effect of combined oral contraceptive pills (COCs) consisting of ethinyl estradiol (EE) and desogestrel on the expression of macrophage, natural killer cells, and regulatory T cells of ovarian endometriotic cysts.
Endometriotic cyst wall tissues were collected from women with endometriosis who were treated (n = 22) with COCs (one table per day of EE 0.03 mg and desogestrel 0.15 mg administered for 28 to 35 days before surgery) or untreated (n = 22). The tissues were collected from endometriotic cyst wall during laparoscopic or laparotomy ovarian cystectomy. Immunohistochemistry for anti-CD68, anti-CD56, and anti-forkhead-winged helix transcription factor (FoxP3), a marker for macrophages, natural killer cells, and regulatory T cells, respectively, were investigated.
The median (interquartile range [IQR]) number of anti-CD68 positive cells in the COC group was significantly lower than in the untreated group (12.7; 4.9-19.3) versus 45.7 (26.0-70.7), p < 0.001). Tissue infiltration of anti-CD56 positive cells in endometriotic cyst was significantly higher after the treatment when compared with tissue from untreated group (42.9, 27.4-68.9 versus 25.3 (14.1-37.3; p = 0.009). The number of regulatory T cells was also significantly increased in the COC group (6.3, 2.8-15.5) versus 0 (0-1.8; p < 0.001).
The effects of COC, containing EE 0.30 mg with desogestrel 0.15 mg, on the immune system was demonstrated by a significant decrease in the number of macrophages and an increase in natural killer and regulatory T cells.
免疫反应失调与子宫内膜异位症的发生有关。本研究旨在评估含有乙炔雌二醇(EE)和去氧孕烯的复方口服避孕药(COC)对卵巢子宫内膜异位囊肿中巨噬细胞、自然杀伤细胞和调节性 T 细胞表达的影响。
从接受 COC(在手术前每天服用一片 EE 0.03mg 和去氧孕烯 0.15mg,持续 28-35 天)治疗的子宫内膜异位症患者(n=22)或未治疗的患者(n=22)的卵巢子宫内膜异位囊肿壁组织中收集子宫内膜异位症囊肿壁组织。分别使用针对巨噬细胞、自然杀伤细胞和调节性 T 细胞的抗 CD68、抗 CD56 和叉头框翼螺旋转录因子(FoxP3)的免疫组织化学方法进行研究。
COC 组的抗 CD68 阳性细胞中位数(四分位距 [IQR])明显低于未治疗组(12.7;4.9-19.3)比 45.7(26.0-70.7),p<0.001)。与未治疗组相比,治疗后子宫内膜异位囊肿中抗 CD56 阳性细胞的组织浸润明显增加(42.9,27.4-68.9 比 25.3(14.1-37.3;p=0.009)。COC 组的调节性 T 细胞数量也明显增加(6.3,2.8-15.5)比 0(0-1.8;p<0.001)。
含有 EE 0.30mg 和去氧孕烯 0.15mg 的 COC 对免疫系统的影响表现为巨噬细胞数量减少,自然杀伤细胞和调节性 T 细胞增加。